FDA Approved: NOXAFIL — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA approved a supplemental application for NOXAFIL (posaconazole) from Merck Sharp & Dohme LLC, indicating an update to the NDA under the supplemental appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Candidiasis
• Invasive Fungal Infection

Drugs mentioned

• NOXAFIL (POSACONAZOLE)

Snippet

SUPPL AP for NOXAFIL (POSACONAZOLE)